Loading...

Buy Full Version
"In Vitro Diagnostics (IVD) Market"

Let us help you !

Invalid Email.

Please Select Country.

Invalid contact no.

Special Symbols Not Allowed.

Invalid Security Code.

Thank You For Your Interest.

We've Successfully Got Your Message,

Our Executive will get back to you Shortly.

In Vitro Diagnostics (IVD) Market by Product Type (Reagents, Instruments, and Software & Services), Technique (Immunodiagnostics, Hematology, Molecular Diagnostics, Tissue Diagnostics, Clinical Chemistry, and Other IVD Techniques), Application (Infectious Diseases, Cancer, Cardiac Diseases, Immune System Disorders, Nephrological Diseases, Gastrointestinal Diseases, and Other Indications), and End User (Standalone Laboratory, Hospitals, Academic & Medical Schools, Point of Care Testing, and Others): Global Opportunity Analysis and Industry Forecast, 2018 - 2025

LI_17336
Pages: 377
Dec 2018 | 48954 Views
 
Author(s) : Sanjivan Gill & Onkar Sumant
Tables: 153
Charts: 81
 

IVD Market Overview:

The global in vitro diagnostics market was valued at $64,479 million in 2017, and is estimated to reach at $93,614 million by 2025, registering a CAGR of 4.8% from 2018 to 2025.

In Vitro Diagnostics (IVD) is used to detect any kind of infection and diseases by taking the specimen from the human body to cure diseases or its sequelae. These in vitro diagnostics products can be instruments, reagents, or any system used for the diagnosis of diseases. Increase in incidence of chronic and infectious diseases and growth in geriatric population drive the global IVD market. In addition, growth in the number of public and private diagnostic centers and point of care testing centers is expected to fuel the in vitro diagnostics market growth during the analysis period. Furthermore, rise in investment for the advancement of healthcare sector by government is anticipated to boost the market growth. However, stringent government regulations for the manufacturing of IVD products and inadequate reimbursement policies are expected to hamper the growth of in vitro diagnostics market. Ongoing R&D activities related to IVD are anticipated to provide new opportunities for the market growth.

Get more information on this report : Request Sample Pages

The global in vitro diagnostics market is segmented based on product type, technique, application, end user, and region. Based on product type, the market is categorized into reagents, instruments, and software & services. Based on techniques, the market is segmented into immunodiagnostics, hematology, molecular diagnostics, tissue diagnostics, clinical chemistry, and other IVD techniques. Based on application, the market is classified into infectious diseases, cancer, cardiac diseases, immune system disorders, nephrological diseases, gastrointestinal diseases, and other indications. Based on end user, it is divided into hospitals, academic & medical schools, point of care testing, and others.

Based on region, the in vitro diagnostics market is studied across North America (U.S. and Rest of North America), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

Segment review

Based on product type, instrument segment is expected to grow at a CAGR of 6.1% from 2018 to 2025. The growth of the instrument segment is attributed to the recent advancements in IVD instruments. Further, there is a growth in demand for fully automated instruments in market, as they simplify the task and provide more accurate and reliable results.

Get more information on this report : Request Sample Pages

According to application, infectious diseases segment captured the highest IVD market share in 2017 due to increase in prevalence of infectious diseases and rise in preventive healthcare awareness among the population.

Get more information on this report : Request Sample Pages

Asia-Pacific provides lucrative opportunities for the key players operating in the in vitro diagnostics market due to focus of key players in the emerging economies and improvement in the healthcare infrastructure. However, current lack of awareness is estimated to hamper the market growth in Asia-Pacific.
 

Get more information on this report : Request Sample Pages

The report provides an extensive competitive analysis and profiles of the key market players such as Abbott Laboratories; Becton, Dickinson and Company; bioMérieux SA; Bio-Rad Laboratories, Inc.; Danaher Corporation (Beckman Coulter, Inc.); F. Hoffmann-La Roche Ltd., Johnson & Johnson, QIAGEN N.V., Sysmex Corporation, and Thermo Fisher Scientific, Inc.
The other players (these players are not profiled in the report and the same can be included on request) in the value chain include Illumina, Inc., Luminex Corporation. and Siemens Healthcare GmbH.

Key Benefits for IVD Market:

  • This report entails a detailed quantitative analysis of the current IVD market trends from 2017 to 2025 to identify the prevailing opportunities along with strategic assessment of global IVD market.
  • IVD market size and estimations are based on a comprehensive analysis of the applications and developments in the industry.
  • A qualitative analysis based on innovative products facilitates the strategic business planning.
  • The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the global IVD market.

IVD Key Market Segments

By Product Type

  • Reagents
  • Instruments
  • Software & Services

By Techniques

  • Immunodiagnostics
    • Enzyme-Linked Immunosorbent Assay (ELISA)
      • Chemiluminescence Immunoassays (CLIAS)
      • Fluorescence Immunoassays (FIAS)
      • Colorimetric Immunoassays (CIS)
    • Rapid Tests
    • Enzyme-Linked ImmunoSpot Assays (ELISPOT)
    • Radioimmunoassay
    • Western Blot
    • Hematology
  • Molecular Diagnostics
    • Polymerase Chain Reaction (PCR)
    • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Hybridization
    • DNA Diagnostics
    • Microarrays
    • Others
  • Tissue Diagnostics
  • Clinical Chemistry
    • Basic Metabolic Panel
    • Liver Panel
    • Lipid Profile
    • Thyroid Function Panel
    • Renal Profile
    • Electrolyte Panel
    • Specialty Chemicals
  • Other IVD Techniques

By Application

  • Infectious Diseases
  • Cancer
  • Cardiac Diseases
  • Immune System Disorders
  • Nephrological Diseases
  • Gastrointestinal Diseases
  • Other Indications

By End User

  • Standalone Laboratory
  • Hospitals
  • Academic & Medical Schools
  • Point of Care Testing
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

 

CHAPTER 1:    INTRODUCTION

1.1.    Report description
1.2.    Key benefits for stakeholders
1.3.    Key market segments

1.3.1.    List of key players profiled in the report

1.4.    Research methodology

1.4.1.    Secondary research
1.4.2.    Primary research
1.4.3.    Analyst tools and models

CHAPTER 2:    EXECUTIVE SUMMARY

2.1.    Key findings of the study
2.2.    CXO perspective

CHAPTER 3:    MARKET OVERVIEW

3.1.    Market definition and scope
3.2.    Key findings

3.2.1.    Top investment pockets

3.3.    Top winning strategies, 2017
3.4.    Top player positioning, 2017
3.5.    Porters five forces analysis
3.6.    Market dynamics

3.6.1.    Drivers

3.6.1.1.    Increase in incidence of chronic and infectious diseases
3.6.1.2.    Technological advancements in IVD
3.6.1.3.    Emergence of minimal invasive technologies
3.6.1.4.    Increasing government expenditures on healthcare
3.6.1.5.    Increase in popularity of personalized medicine approach

3.6.2.    Restraint

3.6.2.1.    Unclear reimbursement policies
3.6.2.2.    Stringent regulatory policies

3.6.3.    Opportunities

3.6.3.1.    Potential opportunities for outsourcing
3.6.3.2.    Convergence of new technologies

3.6.4.    Impact Analyses

CHAPTER 4:    IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE

4.1.    Overview

4.1.1.    Market size and forecast

4.2.    Reagents

4.2.1.    Key market trends, growth factors, and opportunities
4.2.2.    Market size and forecast, by region
4.2.3.    Market analysis, by country

4.3.    Instruments

4.3.1.    Key market trends, growth factors, and opportunities
4.3.2.    Market size and forecast, by region
4.3.3.    Market analysis, by country

4.4.    Software & Services

4.4.1.    Key market trends, growth factors, and opportunities
4.4.2.    Market size and forecast, by region
4.4.3.    Market analysis, by country

CHAPTER 5:    IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE

5.1.    Overview

5.1.1.    Market size and forecast

5.2.    Immunodiagnostics

5.2.1.    Market size and forecast, by type

5.2.1.1.    Enzyme-Linked Immunosorbent Assay (ELISA)

5.2.1.1.1.    Market size and forecast
5.2.1.1.2.    Chemiluminescence Immunoassay (CLIA)

5.2.1.1.2.1.    Market size and forecast

5.2.1.1.3.    Fluorescence Immunoassay (FIA)

5.2.1.1.3.1.    Market size and forecast

5.2.1.1.4.    Colorimetric Immunoassay (CI)

5.2.1.1.4.1.    Market size and forecast

5.2.1.2.    Rapid Tests

5.2.1.2.1.    Market size and forecast

5.2.1.3.    Enzyme-Linked ImmunoSpot (ELISPOT)

5.2.1.3.1.    Market size and forecast

5.2.1.4.    Radioimmunoassay (RIA)

5.2.1.4.1.    Market size and forecast

5.2.1.5.    Western Blot

5.2.1.5.1.    Market size and forecast

5.2.2.    Market size and forecast, by region
5.2.3.    Market analysis, by country

5.3.    Hematology

5.3.1.    Market size and forecast, by region
5.3.2.    Market share analysis, by country

5.4.    Molecular Diagnostics

5.4.1.    Market size and forecast, by type

5.4.1.1.    Polymerize Chain Reaction (PCR)

5.4.1.1.1.    Market size and forecast

5.4.1.2.    Isothermal Nucleic Acid Technology (INAAT)

5.4.1.2.1.    Market size and forecast

5.4.1.3.    Hybridization

5.4.1.3.1.    Market size and forecast

5.4.1.4.    DNA Diagnostics

5.4.1.4.1.    Market size and forecast

5.4.1.5.    Microarray

5.4.1.5.1.    Market size and forecast

5.4.1.6.    Others

5.4.1.6.1.    Market size and forecast

5.4.2.    Market size and forecast, by region
5.4.3.    Market share analysis, by country

5.5.    Tissue Diagnostics

5.5.1.    Market size and forecast, by region
5.5.2.    Market share analysis, by country

5.6.    Clinical Chemistry

5.6.1.    Market size and forecast, by type

5.6.1.1.    Basic Metabolic Panel

5.6.1.1.1.    Market size and forecast

5.6.1.2.    Liver Panel

5.6.1.2.1.    Market size and forecast

5.6.1.3.    Renal Profile

5.6.1.3.1.    Market size and forecast

5.6.1.4.    Lipid Profile

5.6.1.4.1.    Market size and forecast

5.6.1.5.    Thyroid Function Panel

5.6.1.5.1.    Market size and forecast

5.6.1.6.    Electrolyte Panel

5.6.1.6.1.    Market size and forecast

5.6.1.7.    Specialty Chemicals

5.6.1.7.1.    Market size and forecast

5.6.2.    Market size and forecast, by region
5.6.3.    Market share analysis, by country

5.7.    Others

5.7.1.    Market size and forecast, by region
5.7.2.    Market share analysis, by country

CHAPTER 6:    IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION

6.1.    Overview

6.1.1.    Market size and forecast

6.2.    Infectious Diseases

6.2.1.    Market size and forecast, by region
6.2.2.    Market share analysis

6.3.    Cancer

6.3.1.    Market size and forecast, by region
6.3.2.    Market share analysis, by country

6.4.    Cardiac Diseases

6.4.1.    Market size and forecast, by region
6.4.2.    Market share analysis, by country

6.5.    Immune System Disorders

6.5.1.    Market size and forecast, by region
6.5.2.    Market share analysis, by country

6.6.    Nephrological Diseases

6.6.1.    Market size and forecast, by region
6.6.2.    Market share analysis

6.7.    Gastrointestinal Diseases

6.7.1.    Market size and forecast, by region
6.7.2.    Market share analysis

6.8.    Others

6.8.1.    Market size and forecast, by region
6.8.2.    Market share analysis

CHAPTER 7:    IN-VITRO DIAGNOSTICS MARKET, BY END USER

7.1.    Overview

7.1.1.    Market size and forecast

7.2.    Stand-Alone Laboratory

7.2.1.    Market size and forecast, by region
7.2.2.    Market share analysis, by country

7.3.    Hospitals

7.3.1.    Market size and forecast, by region
7.3.2.    Market share analysis, by country

7.4.    Academic & Medical Schools

7.4.1.    Market size and forecast, by region
7.4.2.    Market share analysis

7.5.    Point of Care Testing

7.5.1.    Market size and forecast, by region
7.5.2.    Market share analysis

7.6.    Others

7.6.1.    Market size and forecast, by region
7.6.2.    Market share analysis, by country

CHAPTER 8:    IN-VITRO DIAGNOSTICS MARKET, BY REGION

8.1.    Overview

8.1.1.    Market size and forecast

8.2.    North America

8.2.1.    Key market trends, growth factors, and opportunities
8.2.2.    Market size and forecast, by country

8.2.2.1.    U.S.

8.2.2.1.1.    U.S. In-vitro diagnostics market, by product type
8.2.2.1.2.    U.S. In-vitro diagnostics market, by technique
8.2.2.1.3.    U.S. In-vitro diagnostics market, by application
8.2.2.1.4.    U.S. In-vitro diagnostics market, by end user

8.2.2.2.    Canada

8.2.2.2.1.    Canada In-vitro diagnostics market, by product type
8.2.2.2.2.    Canada In-vitro diagnostics market, by technique
8.2.2.2.3.    Canada In-vitro diagnostics market, by application
8.2.2.2.4.    Canada In-vitro diagnostics market, by end user

8.2.2.3.    Mexico

8.2.2.3.1.    Mexico In-vitro diagnostics market, by product type
8.2.2.3.2.    Mexico In-vitro diagnostics market, by technique
8.2.2.3.3.    Mexico In-vitro diagnostics market, by application
8.2.2.3.4.    Mexico In-vitro diagnostics market, by end user

8.2.3.    Market size and forecast, by product type
8.2.4.    Market size and forecast, by technique
8.2.5.    Market size and forecast, by application
8.2.6.    Market size and forecast, by end user

8.3.    Europe

8.3.1.    Key market trends, growth factors, and opportunities
8.3.2.    Market size and forecast, by country

8.3.2.1.    Germany

8.3.2.1.1.    Germany In-vitro diagnostics market, by product type
8.3.2.1.2.    Germany In-vitro diagnostics market, by technique
8.3.2.1.3.    Germany In-vitro diagnostics market, by application
8.3.2.1.4.    Germany In-vitro diagnostics market, by end user

8.3.2.2.    France

8.3.2.2.1.    France In-vitro diagnostics market, by product type
8.3.2.2.2.    France In-vitro diagnostics market, by technique
8.3.2.2.3.    France In-vitro diagnostics market, by application
8.3.2.2.4.    France In-vitro diagnostics market, by end user

8.3.2.3.    UK

8.3.2.3.1.    UK In-vitro diagnostics market, by product type
8.3.2.3.2.    UK In-vitro diagnostics market, by technique
8.3.2.3.3.    UK In-vitro diagnostics market, by application
8.3.2.3.4.    UK In-vitro diagnostics market, by end user

8.3.2.4.    Italy

8.3.2.4.1.    Italy In-vitro diagnostics market, by product type
8.3.2.4.2.    Italy In-vitro diagnostics market, by technique
8.3.2.4.3.    Italy In-vitro diagnostics market, by application
8.3.2.4.4.    Italy In-vitro diagnostics market, by end user

8.3.2.5.    Spain

8.3.2.5.1.    Spain In-vitro diagnostics market, by product type
8.3.2.5.2.    Spain In-vitro diagnostics market, by technique
8.3.2.5.3.    Spain In-vitro diagnostics market, by application
8.3.2.5.4.    Spain In-vitro diagnostics market, by end user

8.3.2.6.    Rest of Europe

8.3.2.6.1.    Rest of Europe In-vitro diagnostics market, by product t type
8.3.2.6.2.    Rest of Europe In-vitro diagnostics market, by technique
8.3.2.6.3.    Rest of Europe In-vitro diagnostics market, by application
8.3.2.6.4.    Rest of Europe In-vitro diagnostics market, by end user

8.3.3.    Market size and forecast, by product type
8.3.4.    Market size and forecast, by technique
8.3.5.    Market size and forecast, by application
8.3.6.    Market size and forecast, by end user

8.4.    Asia-Pacific

8.4.1.    Key market trends, growth factors, and opportunities
8.4.2.    Market size and forecast, by country

8.4.2.1.    Japan

8.4.2.1.1.    Japan In-vitro diagnostics market, by product type
8.4.2.1.2.    Japan In-vitro diagnostics market, by technique
8.4.2.1.3.    Japan In-vitro diagnostics market, by application
8.4.2.1.4.    Japan In-vitro diagnostics market, by end user

8.4.2.2.    China

8.4.2.2.1.    China In-vitro diagnostics market, by product type
8.4.2.2.2.    China In-vitro diagnostics market, by technique
8.4.2.2.3.    China In-vitro diagnostics market, by application
8.4.2.2.4.    China In-vitro diagnostics market, by end user

8.4.2.3.    Australia

8.4.2.3.1.    Australia In-vitro diagnostics market, by product type
8.4.2.3.2.    Australia In-vitro diagnostics market, by technique
8.4.2.3.3.    Australia In-vitro diagnostics market, by application
8.4.2.3.4.    Australia In-vitro diagnostics market, by end user

8.4.2.4.    India

8.4.2.4.1.    India In-vitro diagnostics market, by product type
8.4.2.4.2.    India In-vitro diagnostics market, by technique
8.4.2.4.3.    India In-vitro diagnostics market, by application
8.4.2.4.4.    India In-vitro diagnostics market, by end user

8.4.2.5.    South Korea

8.4.2.5.1.    South Korea In-vitro diagnostics market, by product type
8.4.2.5.2.    South Korea In-vitro diagnostics market, by technique
8.4.2.5.3.    South Korea In-vitro diagnostics market, by application
8.4.2.5.4.    South Korea In-vitro diagnostics market, by end user

8.4.2.6.    Rest of Asia-Pacific

8.4.2.6.1.    Rest of Asia-Pacific In-vitro diagnostics market, by product type
8.4.2.6.2.    Rest of Asia-Pacific In-vitro diagnostics market, by technique
8.4.2.6.3.    Rest of Asia-Pacific In-vitro diagnostics market, by application
8.4.2.6.4.    Rest of Asia-Pacific In-vitro diagnostics market, by end user

8.4.3.    Market size and forecast, by product type
8.4.4.    Market size and forecast, by technique
8.4.5.    Market size and forecast, by indication
8.4.6.    Market size and forecast, by end user

8.5.    LAMEA

8.5.1.    Key market trends, growth factors, and opportunities
8.5.2.    Market size and forecast, by country

8.5.2.1.    Brazil

8.5.2.1.1.    Brazil In-vitro diagnostics market, by product type
8.5.2.1.2.    Brazil In-vitro diagnostics market, by technique
8.5.2.1.3.    Brazil In-vitro diagnostics market, by application
8.5.2.1.4.    Brazil In-vitro diagnostics market, by end user

8.5.2.2.    Saudi Arabia

8.5.2.2.1.    Saudi Arabia In-vitro diagnostics market, by product type
8.5.2.2.3.    Saudi Arabia In-vitro diagnostics market, by technique
8.5.2.2.4.    Saudi Arabia In-vitro diagnostics market, by application
8.5.2.2.5.    Saudi Arabia In-vitro diagnostics market, by end user

8.5.2.3.    South Africa

8.5.2.3.1.    South Africa In-vitro diagnostics market, by product type
8.5.2.3.2.    South Africa In-vitro diagnostics market, by technique
8.5.2.3.3.    South Africa In-vitro diagnostics market, by application
8.5.2.3.4.    South Africa In-vitro diagnostics market, by end user

8.5.2.4.    Rest of LAMEA

8.5.2.4.1.    Rest of LAMEA In-vitro diagnostics market, by product type
8.5.2.4.2.    Rest of LAMEA In-vitro diagnostics market, by technique
8.5.2.4.3.    Rest of LAMEA In-vitro diagnostics market, by application
8.5.2.4.4.    Rest of LAMEA In-vitro diagnostics market, by end user

8.5.3.    Market size and forecast, by product type
8.5.4.    Market size and forecast, by technique
8.5.5.    Market size and forecast, by application
8.5.6.    Market size and forecast, by end user

CHAPTER 9:    COMPANY PROFILES

9.1.    Abbott Laboratories

9.1.1.    Company overview
9.1.2.    Company snapshot
9.1.3.    Operating business segments
9.1.4.    Product type Portfolio
9.1.5.    Business performance
9.1.6.    Key strategic moves and developments

9.2.    Becton, Dickinson and Company

9.2.1.    Company overview
9.2.2.    Company snapshot
9.2.3.    Operating business segments
9.2.4.    Product type Portfolio
9.2.5.    Business performance
9.2.6.    Key strategic moves and developments

9.3.    bioMérieux SA

9.3.1.    Company overview
9.3.2.    Company snapshot
9.3.3.    Product type portfolio
9.3.4.    Business performance
9.3.5.    Key strategic moves and developments

9.4.    Bio-Rad Laboratories, Inc.

9.4.1.    Company overview
9.4.2.    Company snapshot
9.4.3.    Operating business segments
9.4.4.    Product type Portfolio
9.4.5.    Business performance
9.4.6.    Key strategic moves and developments

9.5.    Danaher Corporation (Beckman Coulter, Inc.)

9.5.1.    Company overview
9.5.2.    Company snapshot
9.5.3.    Operating business segments
9.5.4.    Product type portfolio
9.5.5.    Business performance
9.5.6.    Key strategic moves and developments

9.6.    F. Hoffmann-La Roche Ltd.

9.6.1.    Company overview
9.6.2.    Company snapshot
9.6.3.    Operating business segments
9.6.4.    Product type portfolio
9.6.5.    Business performance
9.6.6.    Key strategic moves and developments

9.7.    Johnson & Johnson

9.7.1.    Company overview
9.7.2.    Company snapshot
9.7.3.    Operating business segments
9.7.4.    Product type Portfolio
9.7.5.    Business performance
9.7.6.    Key strategic moves and developments

9.8.    QIAGEN N.V.

9.8.1.    Company overview
9.8.2.    Company snapshot
9.8.3.    Product type portfolio
9.8.4.    Business performance

9.9.    Sysmex Corporation

9.9.1.    Company overview
9.9.2.    Company snapshot
9.9.3.    Operating business segments
9.9.4.    Product type Portfolio
9.9.5.    Business performance

9.10.    Thermo Fisher Scientific, Inc.

9.10.1.    Company overview
9.10.2.    Company snapshot
9.10.3.    Operating business segments
9.10.4.    Product type Portfolio
9.10.5.    Business performance
9.10.6.    Key strategic moves and developments

LIST OF TABLES

TABLE 01.    GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 02.    IN-VITRO DIAGNOSTICS MARKET FOR REAGENTS, BY REGION, 2016–2023 ($MILLION)
TABLE 03.    IN-VITRO DIAGNOSTICS MARKET FOR INSTRUMENTS, BY REGION, 2017–2025 ($MILLION)
TABLE 04.    IN-VITRO DIAGNOSTICS MARKET FOR SOFTWARE AND SERVICES, BY REGION, 2017–2025 ($MILLION)
TABLE 05.    GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017–2025 ($MILLION)
TABLE 06.    IN-VITRO DIAGNOSTICS MARKET FOR IMMUNO-DIAGNOSTICS, BY TYPE, 2017–2025 ($MILLION)
TABLE 07.    IN-VITRO DIAGNOSTICS MARKET FOR ELISA, BY TYPE 2017–2025 ($MILLION)
TABLE 08.    IN-VITRO DIAGNOSTICS MARKET FOR IMMUNO-DIAGNOSTICS, BY REGION, 2017–2025 ($MILLION)
TABLE 09.    IN-VITRO DIAGNOSTICS MARKET FOR HEMATOLOGY, BY REGION, 2017–2025 ($MILLION)
TABLE 10.    MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2017–2025 ($MILLION)
TABLE 11.    IN-VITRO DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY REGION, 2017–2025 ($MILLION)
TABLE 12.    IN-VITRO DIAGNOSTICS MARKET FOR TISSUE DIAGNOSTICS, BY REGION, 2017–2025 ($MILLION)
TABLE 13.    CLINICAL CHEMISTRY MARKET, BY TYPE, 2017–2025 ($MILLION)
TABLE 14.    IN-VITRO DIAGNOSTICS MARKET FOR CLINICAL CHEMISTRY, BY REGION, 2017–2025 ($MILLION)
TABLE 15.    IN-VITRO DIAGNOSTICS MARKET FOR OTHER IVD TECHNIQUES, BY REGION, 2017–2025 ($MILLION)
TABLE 16.    GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY INDICATION, 2017–2025 ($MILLION)
TABLE 17.    IN-VITRO DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY REGION,2017–2025 ($MILLION)
TABLE 18.    IN-VITRO DIAGNOSTICS MARKET FOR CANCER, BY REGION, 2017–2025 ($MILLION)
TABLE 19.    IN-VITRO DIAGNOSTICS MARKET FOR CARDIAC DISEASES, BY REGION, 2017–2025 ($MILLION)
TABLE 20.    IN-VITRO DIAGNOSTICS MARKET FOR IMMUNE SYSTEM DISORDERS, BY REGION, 2017–2025 ($MILLION)
TABLE 21.    IN-VITRO DIAGNOSTICS MARKET FOR NEPHROLOGICAL DISEASES, BY REGION, 2017–2025 ($MILLION)
TABLE 22.    IN-VITRO DIAGNOSTICS MARKET FOR GASTROINTESTINAL DISEASES, BY REGION, 2017–2025 ($MILLION)
TABLE 23.    IN-VITRO DIAGNOSTICS MARKET FOR OTHER INDICATIONS, BY REGION, 2017–2025 ($MILLION)
TABLE 24.    GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 25.    IN-VITRO DIAGNOSTICS MARKET FOR STAND-ALONE LABORATORY, BY REGION, 2017–2025 ($MILLION)
TABLE 26.    IN-VITRO DIAGNOSTICS MARKET FOR HOSPITALS, BY REGION, 2017–2025 ($MILLION)
TABLE 27.    IN-VITRO DIAGNOSTICS MARKET FOR ACADEMIC AND MEDICAL SCHOOLS, BY REGION,  2017–2025 ($MILLION)
TABLE 28.    IN-VITRO DIAGNOSTICS MARKET FOR POINT OF CARE TESTING, BY REGION,  2017–2025 ($MILLION)
TABLE 29.    IN-VITRO DIAGNOSTICS MARKET FOR OTHERS, BY REGION, 2017–2025 ($MILLION)
TABLE 30.    IN-VITRO DIAGNOSTICS MARKET REVENUE, BY REGION, 2017–2025 ($MILLION)
TABLE 31.    NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 32.    U.S. IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
TABLE 33.    U.S. IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
TABLE 34.    U.S. IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
TABLE 35.    U.S. IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
TABLE 36.    CANADA IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
TABLE 37.    CANADA IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
TABLE 38.    CANADA IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
TABLE 39.    CANADA IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
TABLE 40.    MEXICO IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
TABLE 41.    MEXICO IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
TABLE 42.    MEXICO IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
TABLE 43.    MEXICO IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
TABLE 44.    NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 45.    NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017–2025 ($MILLION)
TABLE 46.    NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 47.    NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 48.    EUROPE IN-VITRO DIAGNOSTICS MARKET, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 49.    GERMANY IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
TABLE 50.    GERMANY IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
TABLE 51.    GERMANY IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
TABLE 52.    GERMANY IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
TABLE 53.    FRANCE IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
TABLE 54.    FRANCE IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
TABLE 55.    FRANCE IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
TABLE 56.    FRANCE IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
TABLE 57.    UK IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
TABLE 58.    UK IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
TABLE 59.    UK IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
TABLE 60.    UK IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
TABLE 61.    ITALY IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
TABLE 62.    ITALY IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
TABLE 63.    ITALY IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
TABLE 64.    ITALY IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
TABLE 65.    SPAIN IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
TABLE 66.    SPAIN IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
TABLE 67.    SPAIN IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
TABLE 68.    SPAIN IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
TABLE 69.    REST OF EUROPE IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
TABLE 70.    REST OF EUROPE IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
TABLE 71.    REST OF EUROPE IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
TABLE 72.    REST OF EUROPE IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
TABLE 73.    EUROPE IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 74.    EUROPE IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017–2025 ($MILLION)
TABLE 75.    EUROPE IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 76.    EUROPE IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 77.    ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 78.    JAPAN IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
TABLE 79.    JAPAN IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
TABLE 80.    JAPAN IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
TABLE 81.    JAPAN IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
TABLE 82.    CHINA IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
TABLE 83.    CHINA IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
TABLE 84.    CHINA IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
TABLE 85.    CHINA IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
TABLE 86.    AUSTRALIA IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
TABLE 87.    AUSTRALIA IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
TABLE 88.    AUSTRALIA IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
TABLE 89.    AUSTRALIA IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
TABLE 90.    INDIA IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
TABLE 91.    INDIA IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
TABLE 92.    INDIA IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
TABLE 93.    INDIA IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
TABLE 94.    SOUTH KOREA IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
TABLE 95.    SOUTH KOREA IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
TABLE 96.    SOUTH KOREA IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
TABLE 97.    SOUTH KOREA IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
TABLE 98.    REST OF ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
TABLE 99.    REST OF ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
TABLE 100.    REST OF ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
TABLE 101.    REST OF ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
TABLE 102.    ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 103.    ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017–2025 ($MILLION)
TABLE 104.    ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET, BY INDICATION, 2017–2025 ($MILLION)
TABLE 105.    ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 106.    LAMEA IN-VITRO DIAGNOSTICS MARKET, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 107.    BRAZIL IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
TABLE 108.    BRAZIL IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
TABLE 109.    BRAZIL IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
TABLE 110.    BRAZIL IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
TABLE 111.    SAUDI ARABIA IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
TABLE 112.    SAUDI ARABIA IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
TABLE 113.    SAUDI ARABIA IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
TABLE 114.    SAUDI ARABIA IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
TABLE 115.    SOUTH AFRICA IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
TABLE 116.    SOUTH AFRICA IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
TABLE 117.    SOUTH AFRICA IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
TABLE 118.    SOUTH AFRICA IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
TABLE 119.    REST OF LAMEA IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
TABLE 120.    REST OF LAMEA IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
TABLE 121.    REST OF LAMEA IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
TABLE 122.    REST OF LAMEA IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
TABLE 123.    LAMEA IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 124.    LAMEA IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017–2025 ($MILLION)
TABLE 125.    LAMEA IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 126.    LAMEA IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 127.    ABBOTT: COMPANY SNAPSHOT
TABLE 128.    ABBOTT: OPERATING SEGMENTS
TABLE 129.    ABBOTT: PRODUCT TYPE PORTFOLIO
TABLE 130.    BD : COMPANY SNAPSHOT
TABLE 131.    BD : OPERATING SEGMENTS
TABLE 132.    BD : PRODUCT TYPE PORTFOLIO
TABLE 133.    BIOMÉRIEUX: COMPANY SNAPSHOT
TABLE 134.    BIOMÉRIEUX: PRODUCT TYPE PORTFOLIO
TABLE 135.    BIO-RAD: COMPANY SNAPSHOT
TABLE 136.    BIO-RAD: OPERATING SEGMENTS
TABLE 137.    BIO-RAD: PRODUCT TYPE PORTFOLIO
TABLE 138.    DANAHER: COMPANY SNAPSHOT
TABLE 139.    DANAHER: OPERATING SEGMENTS
TABLE 140.    DANAHER: PRODUCT TYPE PORTFOLIO
TABLE 141.    ROCHE: COMPANY SNAPSHOT
TABLE 142.    ROCHE: OPERATING SEGMENTS
TABLE 143.    ROCHE: PRODUCT TYPE PORTFOLIO
TABLE 144.    J&J: COMPANY SNAPSHOT
TABLE 145.    J&J: OPERATING SEGMENTS
TABLE 146.    J&J: PRODUCT TYPE PORTFOLIO
TABLE 147.    QIAGEN: COMPANY SNAPSHOT
TABLE 148.    QIAGEN: PRODUCT TYPE PORTFOLIO
TABLE 149.    SYSMEX: COMPANY SNAPSHOT
TABLE 150.    SYSMEX: PRODUCT TYPE PORTFOLIO
TABLE 151.    THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT
TABLE 152.    THERMO FISHER SCIENTIFIC: OPERATING SEGMENTS
TABLE 153.    THERMO FISHER SCIENTIFIC: PRODUCT TYPE PORTFOLIO

LIST OF FIGURES

FIGURE 01.    IN-VITRO DIAGNOSTICS MARKET SEGMENTATION
FIGURE 02.    TOP INVESTMENT POCKETS
FIGURE 03.    TOP WINNING STRATEGIES, 2015-2018
FIGURE 04.    FIGURE 4. TOP WINNING STRATEGIES: NATURE AND TYPE, 2015-2018
FIGURE 05.    TOP PLAYER POSITIONING, 2017
FIGURE 06.    MODERATE BARGANING POWER OF BUYERS
FIGURE 07.    HIGH BARGANING POWER OF SUPPLIERS
FIGURE 08.    MODERATE THREAT OF SUBSTITUTION
FIGURE 09.    LOW THREAT OF NEW ENTRANTS
FIGURE 10.    HIGH COMPETITIVE RIVALRY
FIGURE 11.    IMPACT ANALYSES, IN-VITRO DIAGNOSTICS MARKET
FIGURE 12.    COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR REAGENTS, BY COUNTRY, 2017 & 2025
FIGURE 13.    COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR INSTRUMENTS, BY COUNTRY, 2017 & 2025
FIGURE 14.    COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR SOFTWARE AND SERVICES, BY COUNTRY, 2017 & 2025
FIGURE 15.    CHEMILUMINESCENCE IMMUNOASSAY (CLIA) MARKET, 2017–2025 ($MILLION)
FIGURE 16.    FLUORESENCE IMMUNOASSAY (FIA) MARKET, 2017–2025 ($MILLION)
FIGURE 17.    COLORIMETRIC IMMUNOASSAYS (CI) MARKET, 2017–2025 ($MILLION)
FIGURE 18.    IMMUNO-DIAGNOSTICS MARKET FOR RAPID TESTS, 2017–2025 ($MILLION)
FIGURE 19.    IMMUNO-DIAGNOSTICS MARKET FOR ENZYME-LINKED IMMUNOSPOT (ELISPOT), 2017–2025 ($MILLION)
FIGURE 20.    IMMUNO-DIAGNOSTICS MARKET FOR RADIOIMMUNOASSAYS (RIA), 2017–2025 ($MILLION)
FIGURE 21.    IMMUNO-DIAGNOSTICS MARKET FOR WESTERN BLOT, 2017–2025 ($MILLION)
FIGURE 22.    COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR IMMUNO-DIAGNOSTICS, BY COUNTRY, 2017 & 2025
FIGURE 23.    COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR HEMATOLOGY, BY COUNTRY, 2017 & 2025
FIGURE 24.    MOLECULAR DIAGNOSTICS MARKET FOR POLYMERIZE CHAIN REACTION (PCR), 2017–2025 ($MILLION)
FIGURE 25.    MOLECULAR DIAGNOSTICS MARKET FOR ISOTHERMAL NUCLEIC ACID TECHNOLOGY (INAAT), 2017–2025 ($MILLION)
FIGURE 26.    MOLECULAR DIAGNOSTICS MARKET FOR HYBRIDIZATION, 2017–2025 ($MILLION)
FIGURE 27.    MOLECULAR DIAGNOSTICS MARKET FOR DNA DIAGNOSTICS, 2017–2025 ($MILLION)
FIGURE 28.    MOLECULAR DIAGNOSTICS MARKET FOR MICROARRAY, 2017–2025 ($MILLION)
FIGURE 29.    MOLECULAR DIAGNOSTICS MARKET FOR OTHERS, 2017–2025 ($MILLION)
FIGURE 30.    COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2017 & 2025
FIGURE 31.    COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR TISSUE DIAGNOSTICS, BY COUNTRY, 2017 & 2025
FIGURE 32.    CLINICAL CHEMISTRY MARKET FOR BASIC METABOLIC PANEL, 2017–2025 ($MILLION)
FIGURE 33.    CLINICAL CHEMISTRY MARKET FOR LIVER PANEL, 2017–2025 ($MILLION)
FIGURE 34.    CLINICAL CHEMISTRY MARKET FOR RENAL PROFILE, 2017–2025 ($MILLION)
FIGURE 35.    CLINICAL CHEMISTRY MARKET FOR LIPID PROFILE, 2017–2025 ($MILLION)
FIGURE 36.    CLINICAL CHEMISTRY MARKET FOR THYROID FUNCTION PANEL, 2017–2025 ($MILLION)
FIGURE 37.    CLINICAL CHEMISTRY MARKET FOR ELECTROLYTE PANEL, 2017–2025 ($MILLION)
FIGURE 38.    CLINICAL CHEMISTRY MARKET FOR SPECIALTY CHEMICALS, 2017–2025 ($MILLION)
FIGURE 39.    COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR CLINICAL CHEMISTRY, BY COUNTRY, 2017 & 2025
FIGURE 40.    COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR OTHER IVD TECHNIQUES, BY COUNTRY, 2017 & 2025
FIGURE 41.    COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2017 & 2025
FIGURE 42.    COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR CANCER, BY COUNTRY, 2017 & 2025
FIGURE 43.    COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR CARDIAC DISEASES, BY COUNTRY, 2017 & 2025
FIGURE 44.    COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR IMMUNE SYSTEM DISORDERS, BY COUNTRY, 2017 & 2025
FIGURE 45.    COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR NEPHROLOGICAL DISEASES, BY COUNTRY, 2017 & 2025
FIGURE 46.    COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR GASTROINTESTINAL DISEASES, BY COUNTRY, 2017 & 2025
FIGURE 47.    COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR OTHER INDICATIONS, BY COUNTRY, 2017 & 2025
FIGURE 48.    COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR STAND-ALONE LABORATORY, BY COUNTRY, 2017 & 2025
FIGURE 49.    COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR HOSPITALS, BY COUNTRY, 2017 & 2025
FIGURE 50.    COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR ACADEMIC AND MEDICAL SCHOOLS, BY COUNTRY, 2017 & 2025
FIGURE 51.    COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR POINT OF CARE TESTING, BY COUNTRY, 2017 & 2025
FIGURE 52.    COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR OTHERS, BY COUNTRY, 2017 & 2025
FIGURE 53.    EUROPEAN GERIATRIC POPULATION (ABOVE 65 YEARS), 2017
FIGURE 54.    ABBOTT: NET SALES, 2015–2017 ($MILLION)
FIGURE 55.    ABBOTT: NET SALES SHARE, BY OPERATING SEGMENT, 2017 (%)
FIGURE 56.    ABBOTT: NET SALES SHARE, BY GEOGRAPHY, 2017 (%)
FIGURE 57.    BD: REVENUE, 2015–2017 ($MILLION)
FIGURE 58.    BD: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 59.    BD: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 60.    BIOMÉRIEUX: NET SALES, 2015–2017 ($MILLION)
FIGURE 61.    BIOMÉRIEUX: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 62.    BIO-RAD: NET SALES, 2015–2017 ($MILLION)
FIGURE 63.    BIO-RAD: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 64.    BIO-RAD: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 65.    DANAHER: NET SALES, 2015–2017 ($MILLION)
FIGURE 66.    DANAHER: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 67.    DANAHER: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 68.    ROCHE: NET SALES, 2015–2017 ($MILLION)
FIGURE 69.    ROCHE: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 70.    ROCHE: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 71.    J&J: REVENUE, 2015–2017 ($MILLION)
FIGURE 72.    J&J: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 73.    J&J: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 74.    QIAGEN: NET SALES, 2015–2017 ($MILLION)
FIGURE 75.    QIAGEN: REVENUE SHARE BY PRODUCT TYPE, 2017 (%)
FIGURE 76.    QIAGEN: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 77.    SYSMEX: REVENUE, 2015–2017 ($MILLION)
FIGURE 78.    SYSMEX: REVENUE SHARE, BY GEOGRAPHY, 2017 (%)
FIGURE 79.    THERMO FISHER SCIENTIFIC: REVENUE, 2015–2017 ($MILLION)
FIGURE 80.    THERMO FISHER SCIENTIFIC: REVENUE SHARE, BY SEGMENT, 2017 (%)
FIGURE 81.    THERMO FISHER SCIENTIFIC: REVENUE SHARE, BY GEOGRAPHY, 2017 (%)

 

 
 

In vitro diagnostics (IVD) are the medical devices and accessories used to analyze the samples such as blood, urine, and tissue. These are employed to diagnose a medical condition or any disease. The various conditions that can be diagnosed using IVDs include cancer, infectious diseases, cardiac diseases, nephrological diseases, and others. The rise in incidence of chronic and infectious diseases is the major factor contributing toward the growth of the market. In addition, technological advancements in the field of IVD and emergence of minimally invasive technologies are expected to fuel the growth of the global IVD market. Moreover, growth of the IVD market is also propelled by the escalating government expenditure on healthcare and surge in popularity of personalized medicine approach. However, stringent regulatory policies and unclear reimbursement policies hinder the growth of the global market. Conversely, potential opportunities for outsourcing and convergence of new technologies are anticipated to boost the market growth during the forecast period.

North America accounted for the highest market share due to increase in geriatric population, rise in demand for minimally invasive surgical procedures, and substantial expenditure on healthcare by government reforms. Asia-Pacific possesses the highest market potential due to surge in demand for better healthcare services, significant investments by government to improve healthcare infrastructure, and growth of medical tourism industry in emerging countries.

 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry

Download Sample

Request Customization

Download Sample

OR

Purchase Full Report of
In Vitro Diagnostics (IVD) Market

  • Online Only
  • $3,456
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,370
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $8,995
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 
image image image image image image image image image image image image image image image image image image image
 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

FREQUENTLY ASKED
QUESTIONS?

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 
Download Sample